** Non-GAAP adjustments include the following estimates: stock compensation expense of $17.7 million, intangible asset amortization of $6.4 million, termination costs of $1.6 million, and the associated tax impact from the aforementioned items.

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

April 1,

2023

December 31,

2022

Assets

Current assets:

   Cash and cash equivalents

$   716,377

$   499,915

   Short-term investments

435,699

692,024

   Accounts receivable, net

87,694

71,437

   Inventories

133,236

100,417

   Prepaid expenses and other current assets

87,734

97,570

Total current assets

1,460,740

1,461,363

Property and equipment, net

152,110

152,016

Goodwill

376,389

376,389

Other intangible assets, net

78,397

84,907

Other assets, net

93,812

94,753

Total assets

$2,161,448

$2,169,428

Liabilities and Stockholders' Equity

Current liabilities:

   Accounts payable

$     71,437

$     89,860

   Current portion of convertible debt, net

530,096

--

   Deferred revenue and returns liability

11,258

6,780

   Other current liabilities

80,540

89,136

Total current liabilities

693,331

185,776

Convertible debt, net

--

529,573

Other non-current liabilities

48,663

49,071

Total liabilities

741,994

764,420

Commitments and contingencies

Stockholders' equity:

   Preferred stock – $0.0001 par value; 10,000 shares authorized; no

      shares issued

--

--

   Common stock – $0.0001 par value; 250,000 shares authorized;  

      31,997 and 31,994 shares issued and outstanding at

      April 1, 2023 and December 31, 2022, respectively

3

3

   Retained earnings

1,425,914

1,415,693

   Accumulated other comprehensive loss

(6,463)

(10,688)

Total stockholders' equity

1,419,454

1,405,008

Total liabilities and stockholders' equity

$2,161,448

$2,169,428